Abstract
Purpose
Lung transplantation (LTx) is an established therapy for end-stage lung failure. However, in Japan, the donor organ shortage is extremely severe compared with other developed countries, because of the strict Japanese Organ Transplantation Law. To maximize LTx opportunities in Japan, we have established a special donor evaluation and management system termed the medical consultant (MC) system.
Methods
Data from 171 lung donor candidates registered in Japan from May 1998 to May 2012 were obtained and investigated in a retrospective manner. The candidates were separated into the non-MC-intervened and MC-intervened groups, and then data regarding the PaO2/FiO2 ratio, donation rate and organ survival rate were analyzed and compared between the groups.
Results
The PaO2/FiO2 ratio of the MC-intervened group was ameliorated from the time of first brain death diagnosis to organ harvest. Although the base condition of the MC-intervened group was significantly worse than that of the non-MC-intervened group, the donation rates showed no significant difference (0.64 and 0.66, respectively; p = 0.89). There was a difference in the organ survival rate between the non-MC and MC-intervened groups (5-year survival rates of 67.2 and 88.3 %, respectively; p = 0.16).
Conclusion
The MC system used for organ donor evaluation and management in Japan has achieved acceptable interim results.
Similar content being viewed by others
Abbreviations
- LTx:
-
Lung transplantation
- PaO2/FiO2 :
-
The ratio of arterial oxygen tension to inspired oxygen fraction
- MC:
-
Medical consultant
- UNOS:
-
United Network Organ Sharing
- JOTNW:
-
Japan Organ Transplantation Network
- BD:
-
Brain death
- BFS:
-
Bronchofiberscopy
- 5YSR:
-
5-year survival rate
References
Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med. 1999;340:1081–91.
Snell GI, Griffiths A, Levvey BJ, Oto T. Availability of lungs for transplantation: exploring the real potential of the donor pool. J Heart Lung Transpl. 2008;27:662–7.
de Perrot M, Snell GI, Babcock WD, Meyers BF, Patterson G, Hodges TN, et al. Strategies to optimize the use of currently available lung donors. J Heart Lung Transpl. 2004;23:1127–34.
Bhorade SM, Vigneswaran W, McCabe MA, Garrity ER. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transpl. 2000;19:1199–204.
Botha P, Trivedi D, Weir CJ, Searl CP, Corris PA, Dark JH, et al. Extended donor criteria in lung transplantation: impact on organ allocation. J Thorac Cardiovasc Surg. 2006;131:1154–60.
http://www.eurotransplant.org/cms/index.php?page=yearlystats.
Fukushima N, Ono M, Nakatani T, Minami M, Konaka S, Ashikari J. Strategies for maximizing heart and lung transplantation opportunities in Japan. Transpl Proc. 2009;41:273–6.
Aita K. New organ transplant policies in Japan, including the family-oriented priority donation clause. Transplantation. 2011;91:489–91.
The Japanese Society of Lung and Heart-Lung Transplantation. Registry Report of Japanese Lung Transplantation—2010. Jpn J Transpl. 2010;45:638–40.
Smits JM, Nossent GD, de Vries E, Rahmel A, Meiser B, Strueber M, et al. Evaluation of the lung allocation score in highly urgent and urgent lung transplant candidates in Eurotransplant. J Heart Lung Transpl. 2011;30:22–8.
Arnaoutakis GJ, Allen JG, Merlo CA, Sullivan BE, Baumgartner WA, Conte JV, et al. Impact of the lung allocation score on resource utilization after lung transplantation in the United States. J Heart Lung Transpl. 2011;30:14–21.
Couetil JP, Tolan MJ, Loulmet DF, Guinvarch A, Chevalier PG, Achkar A, et al. Pulmonary bipartitioning and lobar transplantation: a new approach to donor organ shortage. J Thorac Cardiovasc Surg. 1997;113:529–37.
Date H, Aoe M, Nagahiro I, Sano Y, Matsubara H, Goto K, et al. How to predict forced vital capacity after living-donor lobar-lung transplantation. J Heart Lung Transpl. 2004;23:547–51.
Camargo JJ, Irion KL, Marchiori E, Hochhegger B, Porto NS, Moraes BG, et al. Computed tomography measurement of lung volume in preoperative assessment for living donor lung transplantation: volume calculation using 3D surface rendering in the determination of size compatibility. Pediatr Transpl. 2009;13:429–39.
Date H. Update on living-donor lobar lung transplantation. Curr Opin Organ Transpl. 2011;16:453–7.
Cypel M, Keshavjee S. The clinical potential of ex vivo lung perfusion. Expert Rev Respir Med. 2012;6:27–35.
Conflicts of interest
The authors of this manuscript have no conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakagiri, T., Inoue, M., Minami, M. et al. Interim report of the Japanese original donor evaluation and management system: the medical consultant system. Surg Today 44, 1227–1231 (2014). https://doi.org/10.1007/s00595-013-0731-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-013-0731-1